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Background

Purpose
• To determine trends in opioid prescribing for chronic
pain in geriatric patients enrolled with Providence
ElderPlace in Oregon

Labs on
admission:
Objectives

• Discuss trends in opioid prescribing for chronic pain
in geriatric patients at Providence ElderPlace
• Determine if opioids are being safely prescribed at
Providence ElderPlace
• Identify potential gaps that can be addressed to
improve opioid prescribing safety

Results
Table 1. Patient baseline characteristics

Characteristic

Graph 1. Opioid use

(n=168)

Age, years, mean

Non-CII, 6

•

Other, 7

76 (range 57-97)

Sex, female, No. (%)

Morphine,
24

127 (75.6)

•
•
•

Palliative Care, No. (%)
None

108 (64.3)

Stage 1

60 (35.7)

Combo, 4

Oxycodone,
76

Pain History, No. (%)

Norco, 51

Opioid use prior to enrollment

69 (59.0)

PRN

48 (41.0)

72 (42.9)

Non-CII: tramadol (5), codeine (1); Combo: morphine + tramadol (1)
or oxycodone + methadone (3); Other: fentanyl oral (3) and patch (2),
hydromorphone (1), and methadone (1)

PRN = as needed

•
•

117 (69.6)

Scheduled
Active PRN opioid prescription

•
•

Clinical Outcomes

•

Table 2. Primary outcomes by surrogate marker

Outcome

•

No. (%)

MEDD, mg/day, mean

33.6 (range 2.5-360)

Defined functional goals

70 (41.7)

Alternative therapy offered

161 (95.8)

Informed consent

23 (13.7)

Protocol followed

10 (6.0)

•
•
•

MEDD = morphine milligram equivalent daily dose

•
Graph 2. Number of patients per MEDD by palliative stage class
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Safety Outcomes
Graph 3. Falls by average MEDD
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Table 3. Falls and hospitalizations

Outcome

Stage 1

Falls±

60.0
37.4 40.3

1-2

30.0

3-4
Falls

25.0

>5

1–2
3–4
>5

Patient Population
Total of 610 people were originally enrolled in the study.
After screening, 168 patients were utilized to determine the
clinical and safety outcomes.
At baseline, patients were of average of geriatric age (≥65
years old)
Mean age was 76 years (range 57-97 years).
Majority of patients were not of palliative care status.
Opioid use prior to joining ElderPlace was 69.6% of the
study population with majority of use being scheduled
narcotics.
The most used opioid medications were oxycodone and
hydrocodone-acetaminophen followed by morphine.
Additional opioid medications used chronically were
tramadol, codeine, fentanyl, hydromorphone, and
methadone.
Outcomes
The average morphine equivalent daily dose was 33.6 mg
per day.
91, 53, 17 and 7 patients required <25 MEDD, 25-49 MEDD,
50-119 MEDD, and ≥120 MEDD respectively.
Only 41.7% of the patient population had defined functional
goals.
95.8% of patients had alternative forms of pain
management (non-controlled medications, topicals, physical
therapy, acupuncture, etc.) in addition to opioids.
23 (13.7%) patients provided informed consent and 10
followed the current ElderPlace protocol.
Total of 78 falls occurred in 49 different patients. Of those
patients 89.8% had 1-2 falls, 8.2% had 3-4 falls, & 2% had >5
falls.
Total of 67 hospitalizations occurred in 37 different patients- of those, only 18 were opioids related.
Falls were more frequent in Palliative Care Stage 1 patients.
Study Limitations
Retrospective, non-randomized study
Risk of information bias since clinical outcomes determined
via chart review
Short study time frame
Unable to assess compliance, efficacy of current therapy,
and use of PRN medications
Did not assess cause of falls
Specific goals were not defined to determine success

Conclusions

3

0
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• Institutional Review Board (IRB) exempt
• Retrospective electronic health record (EHR) based
study of multiple ElderPlace clinic sites in Oregon.
• All patients meeting inclusion criteria were included
• Study population:
• Providence ElderPlace participants on routine
opioids for chronic pain only (>6 months).
• Study period:
• March 1, 2020 – October 1, 2020
• Exclusion criteria:
• Palliative care Stage 2 and Stage 3
• Outcomes:
• Primary: Trends in opioid prescribing using
surrogate markers such as:
• Average MEDD
• Functional goals of therapy
• Alternative therapy offered/provided
• Informed consent
• ElderPlace protocol use
• Safety: Falls and opioid-related hospitalizations

•

Population

Patients

• Providence ElderPlace in Oregon is the fifth-largest
PACE program in the country that offers wraparound
nursing home-eligible medical and social services to
over 1600 community-dwelling seniors who are
medically frail with complex medication regimens.
• Many elderly patients suffer from chronic nonmalignant pain which may affect their function and
quality of life.
• The Centers for Disease Control and Prevention (CDC)
reports a 7.7% increase in drug overdoses and opioid
deaths in the aging population from 2013 to 2014.
• In 2015-2016 elderly adults obtained an annual
average of 774 Morphine Milligram Equivalents
(MME) of outpatient prescriptions for chronic & acute
pain.
• Multiple comorbidities and age-related changes may
affect distribution, metabolism, and elimination,
older adults are at increased risk of adverse drug
events and reactions.
• Physician prescribing practices has been shown to
play an important role in high rates of prescription
opioid use and misuse.

Discussion

No. (%)
78
44 (89.8)
4 (8.2)
1 (2.0)

Hospitalizations♢

67

Opioid-related*

18+ (48.6)

±Number of cases across 49 different people
♢Number of cases across 37 different people
*Opioid-related defined as altered mental status, fall, pain, or
respiratory depression
+Number of cases across 12 different people

• This study was performed to evaluate trends in opioid
prescribing for chronic pain at Providence ElderPlace in
Oregon.
• Overall, ElderPlace has high compliance at providing
alternative therapy in addition to opioids for pain
management, but minimal compliance with following the
PACE guideline
• Low percentage of patients on opioids experienced falls or
hospitalizations during the study period. No clear
correlation between average MEDD and safety outcomes.
• Room for improvement includes determining clear
functional goals in relation to pain and obtaining a signed
material risk notice (which will enhance ElderPlace protocol
use).
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